Structure Therapeutics (GPCR) Shares Outstanding (Diluted Average) (2023 - 2026)
Quarterly Shares Outstanding (Diluted Average) rose 26.31% to $217.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $217.3 million through Mar 2026, up 26.31% year-over-year, with the annual reading at $177.6 million for FY2025, 12.46% up from the prior year.
Structure Therapeutics' Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $217.3 million for Q1 2026.
- Shares Outstanding (Diluted Average) came in at $217.3 million for Q1 2026, up from $177.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $217.3 million in Q1 2026 to a low of $110.2 million in Q4 2023.
- The 4-year median for Shares Outstanding (Diluted Average) is $171.8 million (2024), against an average of $163.8 million.
- Year-over-year, Shares Outstanding (Diluted Average) surged 43.31% in 2024 and then grew 2.24% in 2025.
- Structure Therapeutics' Shares Outstanding (Diluted Average) stood at $110.2 million in 2023, then skyrocketed by 43.31% to $157.9 million in 2024, then increased by 12.46% to $177.6 million in 2025, then grew by 22.37% to $217.3 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Shares Outstanding (Diluted Average) are $217.3 million (Q1 2026), $177.6 million (Q4 2025), and $175.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 217.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 217.33 Mn |
| Dec 31, 2025 | 177.60 Mn |
| Sep 30, 2025 | 175.47 Mn |
| Jun 30, 2025 | 172.35 Mn |
| Mar 31, 2025 | 172.05 Mn |
| Dec 31, 2024 | 157.92 Mn |
| Sep 30, 2024 | 171.63 Mn |
| Jun 30, 2024 | 143.98 Mn |
| Mar 31, 2024 | 139.71 Mn |
| Dec 31, 2023 | 110.20 Mn |